Status:
COMPLETED
Double-blind Randomized Clinical Trial of Transcranial Magnetic Stimulation in Chronic Migraine
Lead Sponsor:
Hospital Israelita Albert Einstein
Collaborating Sponsors:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Conditions:
Chronic Migraine
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine whether active repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex is safe and effective for preventive treatment of chron...
Detailed Description
Patients with chronic migraine according to the criteria of the International Headache Society will be randomized to either active repetitive transcranial magnetic stimulation of the left dorsolateral...
Eligibility Criteria
Inclusion
- chronic migraine according to the criteria of the International Headache Society
- no change in prophylactic medication in the past 3 months
Exclusion
- other neurological disorders
- bipolar disorder
- alcohol or drug dependence in the past 2 months
- suicidal ideation, psychotic symptoms
- contraindications to transcranial magnetic stimulation (cardiac pacemaker, implanted electronic devices, metal in the skull, skull fractures, history of seizures)
- use of antidepressants in the past 4 weeks
- pregnancy or lack of birth-control method in women of childbearing age
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01496950
Start Date
October 1 2008
End Date
February 1 2012
Last Update
April 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Israelita de Ensino e Pesquisa Albert Einstein
São Paulo, Brazil, 05652901